Tracon Pharmaceuticals, Inc.

Targeted therapies for patients with cancer and other diseases of high unmet need

TRACON Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, age-related macular degeneration (“AMD”) and fibrotic diseases. The Company uses endoglin biology to develop antibodies that bind to the endoglin receptor.